Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Instil Bio (NASDAQ:TIL) through any online brokerage.
Other companies in Instil Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Instil Bio has a consensus price target of $119.00.
The stock price for Instil Bio (NASDAQ: TIL) is $7.025 last updated September 24, 2026 at 5:01 AM EDT.
There are no upcoming dividends for Instil Bio.
Instil Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Instil Bio.
Instil Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.